CeriBell (CBLL) - EV/EBITDA Multiple
CeriBell, Inc. (CBLL) minimizes its environmental impact through cloud optimization while outsourcing the production of electronics for its EEG headbands to third-party contractors. This chart shows an EV/EBITDA market valuation of 0.00. The business generates revenue by implementing software for the rapid detection of seizures in intensive care units and emergency departments, offering physicians subscription-based access to its diagnostic platform.
ceribell.com (CBLL) - metric breakdowns and financial figures
- market price and analyst price targets:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
CBLL - Company Profit|Projected Future Earnings CeriBell, Inc.|CBLL - Price to Earnings Ratio|Projected Price to Earnings CeriBell, Inc.|CBLL - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple CeriBell EEG|CBLL - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) CeriBell|CBLL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months ceribell.com|CBLL - Earnings per share growth in current year|Net earnings per share growth forecast for next year CeriBell, Inc.
Summary company analytics:CeriBell Corp (CBLL)
CeriBell, Inc. (CBLL) develops advanced AI algorithms and wireless rapid-EEG systems for the instantaneous diagnosis of epileptic seizures. The EV/EBITDA multiple compares the total enterprise value, including debt, to operating profit before interest, taxes, depreciation, and amortization. This metric allows an investor to assess the real value of assets relative to the company's ability to generate cash flow. By analyzing the EV/EBITDA trend, one can determine the fundamental valuation trend of the issuer's technological leadership.
Key competitors
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biogen Corp BIIB|Business Value to Operating Income Before Depreciation NBIX|Regencell Bioscience - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio axsome.com AXSM|ACAD: EV/EBITDA Multiple|XENE (Xenon Pharmaceuticals Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VKTX (Viking Pharma) - EV/EBITDA Multiple|Company Value to EBITDA Supernus Corp SUPN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Catalyst Pharmaceuticals (CPRX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DNLI (denalitherapeutics.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Harmony Biosciences Holdings, Inc. HRMY|Biohaven Ltd - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMLX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TRVI (Trevi Corp)|PRAX: EV/EBITDA Multiple|AVXL - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Prothena Corporation plc|Enterprise Value to Operating Income Before Depreciation ALEC (Alector Therapeutics)|EV/EBITDA Multiple ANNX|Enterprise Value to EBITDA Ratio omeros.com OMER|Neurogene Inc. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio acimmune.com (ACIU)|Voyager Therapeutics, Inc. - EV/EBITDA Multiple|Neumora (NMRA) - Enterprise Value to EBITDA Ratio|SCLX: EV/EBITDA Multiple|TVGN (Tevogen Bio Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alpha Cognition Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CGTX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Inhibikase Therapeutics, Inc. (IKT)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAVA (Cassava Sciences Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Assertio ASRT|COYA: Enterprise Value to Operating Income Before Depreciation|VistaGen Therapeutics Inc - EV/EBITDA Multiple|Company Value to EBITDA Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals, Inc.) - Enterprise Value to EBITDA Ratio|CervoMed, Inc. (CRVO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alterity Therapeutics Ltd.|CLNN: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PepGen Inc. (PEPG)|JUNS - Company Value to EBITDA|EV/EBITDA Multiple RLMD (Relmada Therapeutics, Inc.)|ANVS - Enterprise Value to EBITDA Ratio|Grace Tx - EV/EBITDA Multiple|Company Value to EBITDA Firefly Neuro|anewmeds.com (KLTO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NeuroSense Therapeutics Ltd. - Business Value to Operating Income Before Depreciation|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - EV/EBITDA Multiple|MetaVia, Inc. (MTVA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NRXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HSDT (heliusmedical.com)|EV/EBITDA Multiple PASG (Passage Bio)|Neuphoria Therapeutics, Inc. (NEUP) - Company Value to EBITDA|NERV - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ATHA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Addex Therapeutics, Ltd. (ADXN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ALZN (Alzamend Neuro) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio CYCN|PTIX: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KTTA|Total Company Value to Operating Income Before Depreciation Ratio cortigent.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avenue Therapeutics, Inc ATXI|BCLI: Enterprise Value to Operating Income Before Depreciation|Cara Therapeutics, Inc. - EV/EBITDA Multiple|chromocell.com (CHRO) - Enterprise Value to EBITDA Ratio|ELYM (eliemtx.com) - Enterprise Value to EBITDA Ratio|ITCI - Total Company Value to Operating Income Before Depreciation Ratio|LBPH (Longboard Pharma) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Marinus Pharma (MRNS)|EV/EBITDA Multiple NKGN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NRBO (neurobopharma.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sage Therapeutics SAGE|Synaptogenix Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TRVN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VIGL: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Anew Medical, Inc. (WENA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation CERE
